Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2016 - 2025)

Sonoma Pharmaceuticals has reported Exchange Rate Effect over the past 16 years, most recently at $127000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 212.39% year-over-year to $127000.0; the TTM value through Dec 2025 reached $712000.0, up 198.34%, while the annual FY2025 figure was -$616000.0, 2025.0% down from the prior year.
  • Exchange Rate Effect for Q4 2025 was $127000.0 at Sonoma Pharmaceuticals, down from $137000.0 in the prior quarter.
  • Over five years, Exchange Rate Effect peaked at $410000.0 in Q2 2025 and troughed at -$283000.0 in Q3 2024.
  • A 5-year average of $23789.5 and a median of $38000.0 in 2025 define the central range for Exchange Rate Effect.
  • Biggest five-year swings in Exchange Rate Effect: soared 453.85% in 2021 and later crashed 528.89% in 2024.
  • Year by year, Exchange Rate Effect stood at -$46000.0 in 2021, then plummeted by 84.78% to -$85000.0 in 2022, then surged by 165.88% to $56000.0 in 2023, then crashed by 301.79% to -$113000.0 in 2024, then surged by 212.39% to $127000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for SNOA at $127000.0 in Q4 2025, $137000.0 in Q3 2025, and $410000.0 in Q2 2025.